SKI Market

Indian Indices

Sensex

75,930.20 -933.51
( -1.21%)

Global Indices

Nasdaq

47,431.94 -295.58
(-0.62%)

Dow Jones

6,795.43 -7.05
(-0.10%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

91.90 -0.24
(-0.26%)

EUR-INR

106.87 0.29
(0.27%)

GBP-INR

123.51 0.42
(0.34%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vesuvius India Ltd

Industry : Refractories / Intermediates

BSE Code

ISIN Demat

Book Value()

520113

INE386A01023

81.9806623

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VESUVIUS

38.7

10219.08

EPS(TTM)

Face Value()

Div & Yield %

13.01

Back

Sun Pharmaceutical Industries consolidated net profit rises 16.03% in the December 2025 quarter

Jan 31,2026

Net profit of Sun Pharmaceutical Industries rose 16.03% to Rs 3368.81 crore in the quarter ended December 2025 as against Rs 2903.38 crore during the previous quarter ended December 2024. Sales rose 15.12% to Rs 15469.07 crore in the quarter ended December 2025 as against Rs 13436.94 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15469.07	13436.94	15
OPM %	31.99	29.84	-
PBDT	5448.97	4423.13	23
PBT	4716.64	3792.57	24
NP	3368.81	2903.38	16

75,930.20 -933.51 ( -1.21%)

47,431.94 -295.58 (-0.62%)

6,795.43 -7.05 (-0.10%)

55,018.23 769.84 (1.42%)

10,315.38 -96.86 (-0.93%)

91.90 -0.24 (-0.26%)

106.87 0.29 (0.27%)

123.51 0.42 (0.34%)

0.58 0.00 (0.09%)